Antonio Antela

870 total citations
19 papers, 641 citations indexed

About

Antonio Antela is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Antonio Antela has authored 19 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Antonio Antela's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Antonio Antela is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (12 papers). Antonio Antela collaborates with scholars based in Spain and United States. Antonio Antela's co-authors include Maria Jesús Pérez‐Elías, José L. Casado, Fernando Dronda, Santiago Moreno, Ana Moreno, Carmen Quereda, Paloma Martí-Belda, Jesús Blázquez, Leonor Moreno and Rafael Bárcena and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Antonio Antela

19 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Antela Spain	14	501	395	191	141	136	19	641
Anna Danise Italy	13	382 0.8×	289 0.7×	128 0.7×	104 0.7×	57 0.4×	24	504
Martin Gartland United Kingdom	11	794 1.6×	634 1.6×	117 0.6×	262 1.9×	42 0.3×	19	866
Teresa García-Benayas Spain	13	395 0.8×	289 0.7×	85 0.4×	182 1.3×	29 0.2×	18	482
Annapaola Callegaro Italy	11	496 1.0×	426 1.1×	132 0.7×	115 0.8×	14 0.1×	24	588
Mervyn Tyrer United Kingdom	15	668 1.3×	496 1.3×	227 1.2×	143 1.0×	19 0.1×	27	820
Roberta Gagliardini Italy	15	411 0.8×	281 0.7×	129 0.7×	120 0.9×	67 0.5×	65	544
Christiane Moecklinghoff Germany	14	592 1.2×	492 1.2×	103 0.5×	258 1.8×	25 0.2×	34	728
Piedad Arazo Spain	10	313 0.6×	160 0.4×	236 1.2×	58 0.4×	211 1.6×	32	462
M Losso Argentina	7	477 1.0×	331 0.8×	326 1.7×	152 1.1×	286 2.1×	9	733
Radjin Steingrover Netherlands	11	381 0.8×	418 1.1×	89 0.5×	135 1.0×	23 0.2×	15	530

Countries citing papers authored by Antonio Antela

Since Specialization

Citations

This map shows the geographic impact of Antonio Antela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Antela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Antela more than expected).

Fields of papers citing papers by Antonio Antela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Antela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Antela. The network helps show where Antonio Antela may publish in the future.

Co-authorship network of co-authors of Antonio Antela

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Antela. A scholar is included among the top collaborators of Antonio Antela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Antela. Antonio Antela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Llibre, Josep M., H. Álvarez, Antonio Antela, et al.. (2016). Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial. Journal of Antimicrobial Chemotherapy. 71(5). 1346–1351. 3 indexed citations

Llibre, Josep M., Peré Domingo, Rosario Palacios, et al.. (2006). Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir. AIDS. 20(10). 1407–1414. 68 indexed citations

Casado, José L., et al.. (2006). Validation of a Specific Questionnaire on Psychological and Social Repercussions of the Lipodystrophy Syndrome in HIV-infected Patients. Quality of Life Research. 15(5). 767–775. 21 indexed citations

Quereda, Carmen, Santiago Moreno, Leonor Moreno, et al.. (2004). The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Human Pathology. 35(9). 1083–1087. 13 indexed citations

Dronda, Fernando, Javier Zamora, Santiago Moreno, et al.. (2004). CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients. AIDS. 18(16). 2210–2212. 30 indexed citations

Moreno, Leonor, Carmen Quereda, Ana Moreno, et al.. (2004). Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS. 18(1). 67–73. 87 indexed citations

Moreno, Ana, Rafael Bárcena, Carmen Quereda, et al.. (2004). Partial Splenic Embolization for the Treatment of Hypersplenism in Cirrhotic HIV/HCV Patients Prior to Pegylated Interferon and Ribavirin. Antiviral Therapy. 9(6). 1027–1030. 13 indexed citations

Casado, José L., Paloma Martí-Belda, Antonio Antela, et al.. (2003). Overcoming Resistance: Virologic Response to a Salvage Regimen with the Combination of Ritonavir plus Indinavir. HIV Clinical Trials. 4(1). 21–28. 2 indexed citations

Pérez‐Elías, Maria Jesús, Isabel García-Arata, Ignacio de los Santos, et al.. (2003). Phenotype or Virtual Phenotype for Choosing Antiretroviral Therapy after Failure: A Prospective, Randomized Study. Antiviral Therapy. 8(6). 577–584. 36 indexed citations

10.

Casado, José L., Santiago Moreno, Kurt Hertogs, et al.. (2002). Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen. AIDS. 16(1). 47–52. 20 indexed citations

11.

Rubio, Rafael, Juan Berenguer, José M. Miró, et al.. (2002). Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002. Enfermedades Infecciosas y Microbiología Clínica. 20(6). 244–303. 38 indexed citations

12.

Dronda, Fernando, Santiago Moreno, Ana Moreno, et al.. (2002). Long‐Term Outcomes among Antiretroviral‐Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4⁺Cell Counts after Successful Virologic Suppression. Clinical Infectious Diseases. 35(8). 1005–1009. 75 indexed citations

13.

Casado, José L., Fernando Dronda, Kurt Hertogs, et al.. (2001). Efficacy, Tolerance, and Pharmacokinetics of the Combination of Stavudine, Nevirapine, Nelfinavir, and Saquinavir as Salvage Regimen after Ritonavir or Indinavir Failure. AIDS Research and Human Retroviruses. 17(2). 93–98. 12 indexed citations

14.

Pérez‐Elías, Maria Jesús, Randall Lanier, Isabel García-Arata, et al.. (2000). Phenotypic testing predicts virological response in successive protease inhibitor-based regimens. AIDS. 14(9). F95–F101. 20 indexed citations

15.

Casado, José L., Ana Moreno, Paloma Martí-Belda, et al.. (2000). A Clinical Study of the Combination of 100 mg Ritonavir plus 800 mg Indinavir as Salvage Therapy: Influence of Increased Plasma Drug Levels in the Rate of Response. HIV Clinical Trials. 1(1). 13–19. 20 indexed citations

16.

Knobel, Hernando, C Codina, Alexia Carmona, et al.. (2000). [The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].. PubMed. 18(1). 27–39. 27 indexed citations

17.

Casado, José L., Maria Jesús Pérez‐Elías, Antonio Antela, et al.. (1999). Percentage of Adherence Correlates with the Risk of Protease Inhibitor (PI) Treatment Failure in HIV-Infected Patients. Antiviral Therapy. 4(3). 157–161. 23 indexed citations

18.

Casado, José L., Maria Jesús Pérez‐Elías, Antonio Antela, et al.. (1998). Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. AIDS. 12(11). F131–F135. 109 indexed citations

19.

Casado, José L., Maria Jesús Pérez‐Elías, Antonio Antela, et al.. (1998). Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(2). 130–134. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact